| Structure |
Chemical Name |
CAS |
MF |
 |
N-De(4-sulfonaMidophenyl)-N'-(4-sulfonaMidophenyl) Celecoxib |
331943-04-5 |
C17H14F3N3O2S |
 |
Vardenafil hydrochloride trihydrate |
330808-88-3 |
C23H35ClN6O5S |
 |
3S, 5S enantioMer of Atorvastatin CalciuM |
1105067-88-6 |
C33H34CaFN2O5+ |
 |
C00984 |
3646-73-9 |
C6H12O6 |
 |
ISO-MALATHION |
3344-12-5 |
C10H19O6PS2 |
 |
FLUCONAZOLE RELATED COMPOUND B (10 MG) (2-(4-FLUOROPHENYL)-1,3-BIS(1 H-1,2,4-TRIAZOL-1 -YL)-PROPAN-2-OL) |
81886-51-3 |
C13H13FN6O |
 |
INTERFERON ALFA-2B |
99210-65-8 |
|
![Telmisartan Related Compound B (15 mg) (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid)](/CAS/GIF/1026353-20-7.gif) |
Telmisartan Related Compound B (15 mg) (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid) |
1026353-20-7 |
C33H30N4O2 |
 |
Loperamide |
106900-12-3 |
C29H33ClN2O3 |
 |
2,4-Diamino-6-phenyl-7-pteridinol |
19152-93-3 |
C12H10N6O |
![1-[3-(4-tert-Butylbenzoyl)propyl]-4-hydroxypiperidine](/CAS/GIF/97928-18-2.gif) |
1-[3-(4-tert-Butylbenzoyl)propyl]-4-hydroxypiperidine |
97928-18-2 |
C19H29NO2 |
 |
PEAK E |
132685-02-0 |
C24H26N4O4 |
 |
Propylendilaurat |
22788-19-8 |
C27H52O4 |
 |
Atorvastatin Related Compound C |
693793-53-2 |
C33H36CaF2N2O5 |
![Endo-3-amine-9-methyl-9-azabicyclo[3,3,1]nonane](/CAS/GIF/107007-95-4.gif) |
Endo-3-amine-9-methyl-9-azabicyclo[3,3,1]nonane |
107007-95-4 |
C17 H22 N4 O |
 |
rac 5-Desfluoro Voriconazole |
182369-73-9 |
C16H15F2N5O |
![rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol](/CAS/GIF/56718-76-4.gif) |
rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol |
56718-76-4 |
C12H17ClO3 |
 |
eicosapentaenoic acid ethyl ester |
73310-10-8 |
C22H34O2 |
![N-[[(HEXAHYDROCYCLOPENTA [C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-2-METHYL BENZENESULFONAMIDE](/StructureFile/ChemBookStructure9/GIF/CB1271199.gif) |
N-[[(HEXAHYDROCYCLOPENTA [C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-2-METHYL BENZENESULFONAMIDE |
1076198-18-9 |
C15H21N3O3S |
![HALOPERIDOL RELATED COMPOUND A (15 MG) (4,4'-BIS[(4-P-CHLOROPHENYL)-4-HYDROXY-PIPERIDINO]-BU-TYROPHENONE)](/CAS/GIF/67987-08-0.gif) |
HALOPERIDOL RELATED COMPOUND A (15 MG) (4,4'-BIS[(4-P-CHLOROPHENYL)-4-HYDROXY-PIPERIDINO]-BU-TYROPHENONE) |
67987-08-0 |
C32H36Cl2N2O3 |
![3-Amino-2,4,6-triiod-5-[(methylamino)carbonyl]benzoesure](/CAS/GIF/2280-89-9.gif) |
3-Amino-2,4,6-triiod-5-[(methylamino)carbonyl]benzoesure |
2280-89-9 |
C9H7I3N2O3 |
![4-(Benzyloxy)-α-[[tert-butylamino]methyl]-m-xylol-α,α'-diol](/CAS/GIF/56796-66-8.gif) |
4-(Benzyloxy)-α-[[tert-butylamino]methyl]-m-xylol-α,α'-diol |
56796-66-8 |
C20H27NO3 |
 |
LEVODOPA RELATED COMPOUND A (50 MG) (3-(3,4,6-TRIHYDROXYPHENYL)-ALANINE) |
27244-64-0 |
C9H11NO5 |
 |
ALLOPURINOL IMPURITY C |
1346604-13-4 |
C6H6N6O |
 |
17R-Drospirenone |
90457-65-1 |
C24H30O3 |
 |
Benzoic acid, 2-(hexahydro-1-Methyl-1H-azepin-4-yl)hydrazide |
110406-94-5 |
C14H21N3O |
 |
3,3'-Dithiodi-D-valin |
20902-45-8 |
C10H20N2O4S2 |
 |
9,11-Didehydroestriol |
246021-20-5 |
C18H22O3 |
 |
OXYBUTYNIN IMPURITY A |
1199574-71-4 |
C22H35NO3 |
 |
benazepril hydrochloride |
215447-89-5 |
C24H28N2O5HCl |
 |
L-Nateglinide |
105816-05-5 |
C19H27NO3 |
 |
(1S–4R)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride |
172015-79-1 |
C11H12ClN5O.ClH |
 |
2,2'-Binaphthalene-6,6'-dicarboxylic Acid |
932033-58-4 |
C22H14O4 |
 |
DESETHYLENE CIPROFLOXACIN, HYDROCHLORIDE |
528851-31-2 |
C15H16FN3O3.ClH |
 |
exo-Granisetron (Granisetron Impurity F) |
127472-42-8 |
C18H24N4O |
 |
(5α)-7,8-Didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-on |
508-54-3 |
C18H19NO4 |
 |
4-O-BETA-GALACTOPYRANOSYL-D-MANNOPYRANOSE |
50468-56-9 |
C12H22O11 |
![Des[2-[(2-Hydroxyethyl)aMino]ethyl] Mitoxantrone
(Mitoxantrone IMpurity A)](/CAS/GIF/89991-52-6.gif) |
Des[2-[(2-Hydroxyethyl)aMino]ethyl] Mitoxantrone
(Mitoxantrone IMpurity A) |
89991-52-6 |
C18H19N3O5 |
 |
Citalopram hydrochloride |
85118-27-0 |
C20H22ClFN2O |
![alpha-[2-Fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol](/CAS/GIF/871550-15-1.gif) |
alpha-[2-Fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol |
871550-15-1 |
C15H14FN9O |
 |
TIZANIDINE RELATED COMPOUND C (50 MG) (1-ACETYLIMIDAZOLIDINE-2-THIONE) |
5391-52-6 |
C5H8N2OS |
 |
CROTONYLBETAINE(CARNITINE IMPURITY)(RG) |
927-89-9 |
C16H30N2O6 |
![3-[(4-Chlorphenyl)methylen]phthalid](/CAS/GIF/20526-97-0.gif) |
3-[(4-Chlorphenyl)methylen]phthalid |
20526-97-0 |
C15H9ClO2 |
 |
PN 203-831 |
116169-18-7 |
C19H19N3O5 |
 |
Pramipexole Impurity 16 |
104632-27-1 |
C10H18ClN3S |
 |
cis-Glimepiride |
684286-46-2 |
C24H34N4O5S |
 |
ent-Voriconazole |
137234-63-0 |
C16H14F3N5O |
|
|
Chitosan Hydrochloride |
70694-72-3 |
|
 |
Calcipotriol Monohydrate |
147657-22-5 |
C27H42O4 |
 |
2-(4-Chlor-3-sulfamoylbenzoyl)benzoesure |
5270-74-6 |
C14H10ClNO5S |
 |
dihydromevinolin |
77517-29-4 |
C24H38O5 |
 |
PACLITAXEL C |
153415-45-3 |
C46H57NO14 |
 |
FaMotidine AMide IMpurity |
76824-16-3 |
C8H13N5OS2 |
 |
CITALOPRAM RELATED COMPOUND F (200 MG) (DIMETHYL-(1-METHYL-3,3-DIPHENYL-ALLYL)-AMINE HYDROCHLORIDE) |
55011-89-7 |
C18H22ClN |
 |
2-(3-CARBOXYPHENYL)PROPIONIC ACID |
68432-95-1 |
C10H10O4 |
 |
Desfluoro Risperidone |
106266-09-5 |
C23H28N4O2 |
 |
Labetalol IMpurity A |
1391051-99-2 |
C19H23NO4 |
 |
Cetirizine Ethyl Ester (USP RC A) |
246870-46-2 |
C23H29ClN2O3 |
 |
6,6'-DiMethoxy-2,2'-binaphthalene |
29619-45-2 |
C22H18O2 |
 |
Levomepromazinhydrochlorid |
1236-99-3 |
C19H24N2OS.ClH |
 |
Prednisolon-21-pivalat |
1107-99-9 |
C26H36O6 |
|
|
Citalopram Related Compound E |
|
|
 |
Dehydronitrendipine |
89267-41-4 |
C18H18N2O6 |
![7-AMINO-3-[(Z)-PROP-1-ENYL]-3-CEPHEM-4-CARBOXYLIC ACID](/CAS/GIF/106447-44-3.gif) |
7-AMINO-3-[(Z)-PROP-1-ENYL]-3-CEPHEM-4-CARBOXYLIC ACID |
106447-44-3 |
C10H12N2O3S |
 |
Repaglinide EP Impurity E |
147852-26-4 |
C27H36N2O4 |
 |
Atorvastatin Related Compound A |
433289-83-9 |
C33H35CaN2O5+ |
 |
(5α,6α)-7,8-Didehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan |
2859-16-7 |
C19H23NO3 |
 |
4-Cyclohexyl-α-methylnaphthalin-1-essigsure |
71109-09-6 |
C19H22O2 |
 |
SalMeterol Xinafoate Adduct IMpurity |
1330076-52-2 |
C36H43NO6 |
 |
Ticabesone Propionate |
73205-13-7 |
C25H32F2O5S |
 |
PYRANTEL IMPURITY A |
36700-38-6 |
C11H14N2S |
 |
Chlorcyclizinhydrochlorid |
14362-31-3 |
C18H22Cl2N2 |
 |
2-(Acetylsulfanyl)ethanesulphonic |
69536-71-6 |
C4H8O4S2 |
|
|
HIDE POWDER |
|
|
 |
TIZANIDINE RELATED COMPOUND B (50 MG) (N-ACETYLTIZANIDINE) |
173532-15-5 |
C11H10ClN5OS |
![METHYL 6-CHLORO-1H-BENZO[D]IMIDAZOL-2-YLCARBAMATE](/CAS/GIF/20367-38-8.gif) |
METHYL 6-CHLORO-1H-BENZO[D]IMIDAZOL-2-YLCARBAMATE |
20367-38-8 |
C9H8ClN3O2 |
|
|
Fosinopril Related Compound C |
|
|
 |
Meta-Fexofenadine |
479035-75-1 |
C32H39NO4 |
![4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID, 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO-](/CAS/GIF/84378-44-9.gif) |
4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID, 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO- |
84378-44-9 |
C13H10FN3O3 |
 |
TINIDAZOLE RELATED COMPOUND B (20 MG) (1-(2-ETHYL-SULFONYLETHYL)-2-METHYL-4-NITROIMIDAZOLE) |
25459-12-5 |
C8H13N3O4S |
 |
DIAZEPAM RELATED COMPOUND B (25 MG) (3-AMINO-6-CHLORO-1-METHYL-4-PHENYLCARBOSTYRIL) |
5220-02-0 |
C16H13ClN2O |
 |
OXOLINIC ACID IMPURITY B |
16172-03-5 |
C15H15NO5 |
 |
(±)-2-methyl-1-nitrosoindoline |
85440-79-5 |
C9H10N2O |
 |
Desmethyl Chlorpheniramine Maleate Salt |
22630-25-7 |
C19H21ClN2O4 |
 |
3-Oxo Ropinirole Hydrochloride
|
221264-21-7 |
C16H23ClN2O2 |
 |
Proguanil Related Compound D (25 mg) (1,5-bis(1-methylethyl)biguanide hydrochloride) |
35708-82-8 |
C8H20ClN5 |
 |
Trospium Chloride Related Compound C |
3464-71-9 |
C16H15ClO2 |
 |
CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE) |
24757-70-8 |
C11H15N5O4 |
 |
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) |
35888-94-9 |
C19H16O4 |
 |
Dalasetron (Mesylate hydrate) |
878143-33-0 |
C20H24N2O6S |
![1,5-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-on](/CAS/GIF/4656-86-4.gif) |
1,5-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-on |
4656-86-4 |
C4H3N5O |
![(±)-N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamid](/CAS/GIF/22568-64-5.gif) |
(±)-N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamid |
22568-64-5 |
C16H24N2O4 |
 |
ethyl 5-(forMylaMino)-1H-pyrazole-4-carboxylate |
31055-19-3 |
C7H9N3O3 |
 |
2,2'-Bis-(1-adaMantyl)-4,4'-diMethoxybiphenyl |
932033-57-3 |
C34H42O2 |
 |
Natrium-2-iodhippurat |
133-17-5 |
C9H7INNaO3 |
![(2S)-1-[2-Methylpropanoyl]-pyrrolidine-2-carboxylic Acid](/CAS/20130318/GIF/CB92605022.gif) |
(2S)-1-[2-Methylpropanoyl]-pyrrolidine-2-carboxylic Acid |
23500-15-4 |
C9H15NO3 |
 |
13-CIS-ACITRETIN |
69427-46-9 |
C21H26O3 |
 |
YTTERBIUM(III) IONOPHORE I |
125110-14-7 |
C16H17N5O8S2 |
|
|
WARFARIN RELATED COMPOUND A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) |
37209-23-7 |
|
![1,3-Dihydro-6-methylfuro[3,4-c]pyridin-7-ol](/CAS/GIF/5196-20-3.gif) |
1,3-Dihydro-6-methylfuro[3,4-c]pyridin-7-ol |
5196-20-3 |
C8H9NO2 |